US Broker Ratings

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 26% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a formidable player in the biotechnology sector, with a compelling narrative that has captured the attention of investors. With..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A High-Valuation Biotech with Strong Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in RNA interference (RNAi) therapeutics, stands out in the biotechnology sector with a significant market capitalization of $59.45 billion...

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating the Potential Upside in a Volatile Market

Investors have their eyes on iRhythm Technologies, Inc. (NASDAQ: IRTC), a standout player in the healthcare sector, particularly in the medical devices industry. Known for its..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a Potential 52.51% Upside in the CNS Therapeutics Market

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, is making waves in the biotechnology sector with its..

AstraZeneca PLC (AZN): Investor Outlook with a 14.54% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (AZN) stands prominently as a global leader in the healthcare sector, with a particular focus on the discovery, development, and commercialization of prescription medicines...

DexCom, Inc. (DXCM) Stock Analysis: A 51% Upside Potential and Strong Buy Consensus

For investors seeking promising opportunities in the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents a compelling case. As a leading player in the medical devices industry,..

Insulet Corporation (PODD) Stock Analysis: A 32.9% Revenue Growth Powerhouse with Robust Buy Ratings

Insulet Corporation (NASDAQ: PODD) continues to make waves in the healthcare sector, specifically within the medical devices industry, with its innovative insulin delivery systems. The company,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Star with 120% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning Australian biotechnology company, is increasingly capturing the attention of investors with its impressive growth trajectory and promising product pipeline...

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Amidst Mixed Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, continues to assert its influence in the drug manufacturing industry, specializing in both..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Potential with an 8.15% Upside

Teleflex Incorporated (NYSE: TFX) stands as a significant player in the healthcare sector, specializing in the design and production of single-use medical devices essential for critical..

Chemed Corp (CHE) Stock Analysis: Exploring a Potential Upside of Nearly 28%

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, specifically within the medical care facilities industry, commands investor attention with its diverse service offerings..

Edwards Lifesciences Corporation (EW) Stock Analysis: A 17.45% Upside Potential with Robust Growth Prospects

Edwards Lifesciences Corporation (EW), a leading player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity for those looking to..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 17% Upside in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company, is gaining significant attention from investors with its focus on rare neuroendocrine diseases and a promising potential..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Exploring an 80.94% Potential Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) is a standout player in the medical devices industry, focusing on innovative solutions for obstructive sleep apnea (OSA). With a..

ADMA Biologics Inc (ADMA) Stock Analysis: 82.65% Potential Upside Ignites Investor Interest

ADMA Biologics Inc (ADMA), a key player in the biotechnology sector, is capturing significant attention from investors, fueled by a notable potential upside of 82.65%. As..

Cardinal Health, Inc. (CAH) Stock Analysis: Evaluating a 20.85% Potential Upside in the Healthcare Sector

Cardinal Health, Inc. (NYSE: CAH), a key player in the healthcare sector, offers a compelling opportunity for investors, with analysts predicting a potential upside of 20.85%...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring a 37.46% Potential Upside Amidst a Tumultuous Market

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a beacon of innovation in the biotechnology sector, with its focus on RNA-targeted therapeutics and gene therapies for rare..

Boston Scientific Corporation (BSX) Stock Analysis: Promising 27% Upside Potential Amid Robust Growth

Boston Scientific Corporation (NYSE: BSX), a prominent player in the healthcare sector, particularly within the medical devices industry, is capturing investor attention with a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a Potential 1.98% Upside in the Pharmaceutical Space

Dr. Reddy’s Laboratories Ltd (RDY) stands as a formidable player in the global pharmaceutical industry, with a notable presence in North America, Europe, India, and Russia...

Encompass Health Corporation (EHC): Investor Outlook on a Healthcare Leader with a 10.77% Upside Potential

For those keen on the healthcare sector, Encompass Health Corporation (NYSE: EHC) presents a compelling investment opportunity. With a market capitalization of $12.5 billion, this Birmingham,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds